ChartMill · Apr 9, 2026
IMAX CORP (NYSE:IMAX) Presents a High-Growth Momentum and Technical Breakout Setup
IMAX stock shows strong earnings momentum and a bullish technical setup, offering a potential breakout opportunity for growth investors.
IM
NASDAQ · IMAX
IMAX Corporation
Communication Services · Entertainment
$52.77
Down-$0.66 (-1.24%)
Updated Sep 16, 2026, 11:06 AM
SID Score
6.0/10
Composite research score
Smart Money
—
Institutional and insider signal
- Market cap
- 2.06B
- P/E ratio
- 52.08
- Dividend yield
- 0.00%
- 52-week range
- $30.74 – $55.57
- Volume
- 926.29K
- Avg. volume
- 1.29M
Price performance
IMAX price history
1M range · 20 trading sessions · Daily adjusted prices
IMAX closed at $52.77 after 20 trading sessions, up 4.39% for the selected period.
- Last close
- $52.77
- Period change
- +4.39%
- Period low
- $50.38
- Period high
- $54.79
Daily close
View OHLC price history
| Date | Open | High | Low | Close | Volume |
|---|---|---|---|---|---|
| Sep 15, 2026 | $53.27 | $53.74 | $52.53 | $52.77 | 926.29K |
| Sep 14, 2026 | $52.05 | $53.755 | $52.05 | $53.43 | 1.1M |
| Sep 11, 2026 | $51.71 | $52.415 | $50.95 | $52.09 | 1.19M |
| Sep 10, 2026 | $51.36 | $52.45 | $50.666 | $51.35 | 610.98K |
| Sep 9, 2026 | $52.36 | $52.36 | $51.005 | $51.60 | 784.27K |
| Sep 8, 2026 | $51.09 | $52.91 | $50.52 | $52.66 | 1.45M |
| Sep 4, 2026 | $52.52 | $53.165 | $51.63 | $51.64 | 460.9K |
| Sep 3, 2026 | $52.49 | $52.76 | $51.53 | $51.92 | 699.86K |
| Sep 2, 2026 | $51.31 | $52.545 | $51.31 | $51.68 | 523.27K |
| Sep 1, 2026 | $51.73 | $51.73 | $50.77 | $51.13 | 707.81K |
| Aug 31, 2026 | $50.53 | $51.47 | $50.39 | $51.20 | 927.48K |
| Aug 28, 2026 | $51.21 | $52.31 | $50.03 | $50.38 | 1.1M |
| Aug 27, 2026 | $52.35 | $52.495 | $51.51 | $51.94 | 833.56K |
| Aug 26, 2026 | $53.75 | $54.76 | $52.61 | $52.76 | 747.02K |
| Aug 25, 2026 | $54.88 | $54.98 | $53.77 | $53.90 | 1.22M |
| Aug 24, 2026 | $53.16 | $55.5706 | $52.93 | $54.79 | 1.38M |
| Aug 21, 2026 | $52.72 | $53.11 | $52.05 | $52.74 | 632.86K |
| Aug 20, 2026 | $52.90 | $54.50 | $52.22 | $52.74 | 1.27M |
| Aug 19, 2026 | $50.50 | $54.28 | $50.0288 | $53.71 | 1.67M |
| Aug 18, 2026 | $52.26 | $52.39 | $50.54 | $50.55 | 1.13M |
Latest IMAX news
The latest Smart Investors Daily articles mentioning IMAX.
Stock researchCompany · Overview
IMAX research
Overview
Company profile and research snapshot.
Company profile
Imax Corp is a technology platform for entertainment and events. Through its proprietary software, auditorium architecture, patented intellectual property, and specialized equipment, IMAX offers end-to-end solution to create superior, immersive content experiences for which the IMAX brand is globally renowned. The Company has two reportable segments being Content Solutions and Technology Products and Services. The Company leverages its proprietary technology and engineering in all aspects of its business, which principally consists of the IMAX film remastering and the sale or lease of premium IMAX theater systems.
Visit company websiteAnalyst outlook
Consensus and target data currently published for this company.
- Consensus
- —
- Average target
- $41.40
- Implied upside
- —
- Analysts
- —
| Date | Firm | Rating | Target |
|---|---|---|---|
| Sep 9, 2026 | Rosenblatt | Buy | — |
| Sep 4, 2026 | Goldman Sachs | Neutral | — |
| Sep 3, 2026 | Roth Capital | Buy | — |
| Sep 2, 2026 | Macquarie | Outperform | — |
| Aug 24, 2026 | B. Riley Securities | Buy | — |
News briefing
No generated briefing is available yet.
Benzinga · Apr 8, 2026
Seaport Global Maintains Buy on Imax, Raises Price Target to $45
Seaport Global analyst David Joyce maintains Imax (NYSE:IMAX) with a Buy and raises the price target from $43 to $45.
ChartMill · Apr 4, 2026
IMAX CORP (NYSE:IMAX) Meets Key Criteria of the Minervini Trend Template
IMAX stock aligns with Mark Minervini's SEPA strategy, showing strong technical uptrend and high-growth fundamentals like surging EPS.
Benzinga · Mar 30, 2026
IMAX CEO Richard Gelfond Takes Temporary Medical Leave
IMAX Corporation (NYSE:IMAX) today announced CEO Richard Gelfond is on a temporary medical leave of absence as he undergoes treatment for pneumonia. He is receiving outstanding care and progressing in his recovery.While
AI research layers
Interpretive context generated from the platform’s current data sources.
No results
AI research layers have not been published yet.
